We are live on ! Find out more
AP

Andera Partners Portfolio holdings

AUM $177M
This Fund
S&P 500
This Quarter Est. Return
+2.77%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$177M
AUM Growth
Cap. Flow
+$182M
Cap. Flow %
102.98%
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMTS
1
Kestra Medical Technologies
KMTS
$1.43B
$67.4M 38.14%
+2,540,106
New +$65.4M
MLYS icon
2
Mineralys Therapeutics
MLYS
$2.39B
$57.8M 32.71%
+1,591,917
New +$63.8M
EVMN
3
Evommune Inc
EVMN
$437M
$32.5M 18.39%
+1,897,362
New +$35.6M
ABVX
4
Abivax
ABVX
$11.9B
$10.5M 5.97%
+78,125
New +$8.52M
IVA
5
Inventiva
IVA
$1.09B
$8.45M 4.79%
+1,818,181
New +$8.45M

Similar funds

Andera Partners's Q4 2025 Portfolio in Review

Q4 2025 is the first quarter with a 13F filing on record for Andera Partners, which disclosed 5 positions worth $177M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Kestra Medical Technologies: 2,540,106 shares worth $67.4M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Andera Partners's largest Q4 2025 buy was Kestra Medical Technologies: 2,540,106 shares worth $67.4M.
  • Andera Partners's ten largest holdings make up 100% of its $177M portfolio in Q4 2025.
  • Andera Partners disclosed 5 positions in Q4 2025, its first 13F filing on record.

Based on Andera Partners's 13F filing for Q4 2025, filed 17 Feb 2026.